PharmaBoardroom

Swiss Pharma: Staying the Course

This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Brian O’Callaghan – CEO, ObsEva

Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his motivations to join the company –…

Bertrand Ducrey – CEO, Debiopharm

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug improvement, drug delivery, and drug…

Nicolas Fischer – CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

Dan Leonard – President & CEO, Association for…

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities as head of the…

China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan…

The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and dMed’s R&D collab; and investment…

Carl Firth – CEO, ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals why the company has shifted its…

China: Yangtze River Pharmaceutical Group (YRPG) in Profile

One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River Pharmaceutical Group (YRPG) is so-named…

Securing the Conditions to Secure Our Meds

The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar medicines have on US healthcare today and introduces the ‘Secure…

The bright future of mRNA technology – InConversation…

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…

5 US Rare Disease Start-Ups to Watch

Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan therapies in Europe, here we move to…

Tagged with BIO